Jared Aelony, DPM
Foot & Ankle Surgery · Rochester, MNNPI 1932125697
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,550 of the $4,097 with a category attached, or 86.6%. Stryker accounts for 68.4% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2024 at $1,798 and has fallen 71.1% since, to $520 in 2025.
Across 73 payments — averaging $56.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Organogenesis Inc.$401
- Fusion Orthopedics USA, LLC$265
- Smith+Nephew$125
- Johnson & Johnson$118
- Trilliant Surgical LLC.$97
- plus $289 from 10 others
What the payments were for
- Travel & lodging$54813%
- Food & beverage$3,55087%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 52 | $2,802 |
| Organogenesis Inc. | 4 | $401 |
| Fusion Orthopedics USA, LLC | 1 | $265 |
| Smith+Nephew | 1 | $125 |
| Johnson & Johnson | 1 | $118 |
| Trilliant Surgical LLC. | 1 | $97 |
| Orthofix Medical, Inc. | 3 | $68 |
| Gemini Medical LLC | 1 | $40 |
| Medical Device Business Services, Inc. | 1 | $36 |
| Kerecis Limited | 2 | $28 |
| Lifenet Health | 1 | $25 |
| Medtronic | 1 | $22 |
| Bioventus LLC | 1 | $22 |
| Foundation Medical, LLC | 1 | $18 |
| Solventum Corporation | 1 | $16 |
| Paragon 28, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORTHOLOC 3DI$721
- AUGMENT INJECTABLE$472
- ORTHOLOC 2 LAPIFUSE$175
- PROPHECY$175
- 7 X 23MM CITRELOCK IMPLANT$173
- ALLOPURE$173
- PuraPly$140
- INFINITY$132
- Santyl$125
- Affinity$122
- PURAPLY WOUND MATRIX$122
- MOTOBAND$118
How this compares
$4,097 in reported general payments places this provider in the 60th percentile of 102 foot & ankle surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 26 | $603 |
| Ciclopirox | 24 | $567 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 33 | $433 |
| Gabapentin | 14 | $151 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $113 |
| Hydroxyzine Pamoate | 14 | $66 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Rochester
- Laura BuehlerRochester$16K
- Johannes CoetzeeEdina$4.7M
- Troy BoffeliSaint Paul$1.7M
- Jeffrey SeyboldEdina$270K
- Kyle AbbenSt Louis Park$130K
- Collin MesserlySaint Paul$50K
- Ryan ReinkingDuluth$48K
- Kevin MahoneyMarshall$39K
- Bethany StaehnkeCrookston$27K
- Amber WibbelsRoseau$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.